Filing Details
- Accession Number:
- 0001237899-14-000020
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2014-02-13 19:38:09
- Reporting Period:
- 2014-02-12
- Filing Date:
- 2014-02-13
- Accepted Time:
- 2014-02-13 19:38:09
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
872589 | Regeneron Pharmaceuticals Inc | REGN | Pharmaceutical Preparations (2834) | 133444607 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1225472 | M Eric Shooter | 777 Old Saw Mill River Road Tarrytown NY 10591 | Yes | No | No | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock | Acquisiton | 2014-02-12 | 5,000 | $177.82 | 5,000 | No | 4 | M | Direct | |
Common Stock | Acquisiton | 2014-02-12 | 5,000 | $57.11 | 10,000 | No | 4 | M | Direct | |
Common Stock | Acquisiton | 2014-02-12 | 5,000 | $33.42 | 15,000 | No | 4 | M | Direct | |
Common Stock | Disposition | 2014-02-12 | 12,878 | $320.41 | 2,122 | No | 4 | S | Direct | |
Common Stock | Disposition | 2014-02-12 | 2,122 | $321.22 | 0 | No | 4 | S | Direct | |
Common Stock | Acquisiton | 2014-02-12 | 7,000 | $0.00 | 7,000 | No | 4 | C | Indirect | by Trust |
Common Stock | Disposition | 2014-02-12 | 7,000 | $0.00 | 0 | No | 5 | G | Indirect | by Trust |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | M | Direct | |
No | 4 | M | Direct | |
No | 4 | M | Direct | |
No | 4 | S | Direct | |
No | 4 | S | Direct | |
No | 4 | C | Indirect | by Trust |
No | 5 | G | Indirect | by Trust |
Reported Derivative Transactions
Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
---|---|---|---|---|---|---|---|
Common Stock | Class A Stock | Disposition | 2014-02-12 | 7,000 | $0.00 | 7,000 | $0.00 |
Common Stock | Non-Qualified Stock Option (right to buy) | Disposition | 2014-02-12 | 5,000 | $0.00 | 5,000 | $33.42 |
Common Stock | Non-Qualified Stock Option (right to buy) | Disposition | 2014-02-12 | 5,000 | $0.00 | 5,000 | $57.11 |
Common Stock | Non-Qualified Stock Option (right to buy) | Disposition | 2014-02-12 | 5,000 | $0.00 | 5,000 | $177.82 |
Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
---|---|---|---|---|---|---|
85 | No | 4 | C | Indirect | ||
0 | 2021-01-03 | No | 4 | M | Direct | |
5,000 | 2022-01-03 | No | 4 | M | Direct | |
10,000 | 2023-01-02 | No | 4 | M | Direct |
Reported Non-Derivative Holdings
Sec. Name | Remaning Holdings | Nature of Ownership | Explanation |
---|---|---|---|
Common Stock | 2,500 | Indirect | GRAT self |
Common Stock | 2,500 | Indirect | GRAT spouse |
Footnotes
- Represents volume-weighted average price of sales of 12,878 shares of Company stock on February 12, 2014 at prices ranging from $320.00 to $320.91. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on February 12, 2014 at each separate price.
- Represents volume-weighted average price of sales of 2,122 shares of Company stock on February 12, 2014 at prices ranging from $321.00 to $321.49. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on February 12, 2014 at each separate price.
- Gift of Common Stock to a charitable foundation.
- Class A Stock of Regeneron Pharmaceuticals, Inc. ("Regeneron") converts to Common Stock of Regeneron on a one-to-one basis upon certain events or upon election of the shareholder.
- Exercisable date, exercise date, exercise price, purchase price, sales price, and/or expiration date is/are not applicable in this case.
- Shares of Class A Stock are convertible at any time on a share-for-share basis into Common Stock.
- The stock option becomes exercisable in three equal annual installments, commencing one year after the date of grant.